[Carcinoid tumors].
Carcinoids are characteristically indolent, but heterogeneous tumors with respect to their site of origin, endocrine features, clinical manifestations and biologic behaviour. The authors summarize the current laboratory, endoscopic and radiologic methods used for the diagnosis of carcinoid tumors. Treatment modalities should be directed against the tumor and the hormonal excess state. The authors review the outcome of most frequently used therapies, including somatostatin-analogue and interferon treatment, chemotherapy, embolization, receptor-targeted radiotherapy and surgical intervention). Patients with carcinoid tumors, with or without carcinoid syndrome, are best managed by a multidisciplinary approach.
Tóth
Miklós
M
Prónai
László
L
Németh
Anna Mária
AM
Tulassay
Zsolt
Z
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002275:Carcinoid Heart Disease / Q000175:diagnosis / Q000628:therapy; D002276:Carcinoid Tumor / Q000175:diagnosis* / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D003131:Combined Modality Therapy; D003937:Diagnosis, Differential; D005770:Gastrointestinal Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D008303:Malignant Carcinoid Syndrome / Q000175:diagnosis / Q000628:therapy; D015282:Octreotide / Q000627:therapeutic use; D011868:Radioisotopes / Q000627:therapeutic use
D000970:Antineoplastic Agents; D016898:Interferon-alpha; D011868:Radioisotopes; D015282:Octreotide
Carcinoid tumorok.